Cargando…

Inhibition in the amygdala anxiety circuitry

Inhibitory neurotransmission plays a key role in anxiety disorders, as evidenced by the anxiolytic effect of the benzodiazepine class of γ-aminobutyric acid (GABA) receptor agonists and the recent discovery of anxiety-associated variants in the molecular components of inhibitory synapses. Accordingl...

Descripción completa

Detalles Bibliográficos
Autores principales: Babaev, Olga, Piletti Chatain, Carolina, Krueger-Burg, Dilja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938054/
https://www.ncbi.nlm.nih.gov/pubmed/29628509
http://dx.doi.org/10.1038/s12276-018-0063-8
_version_ 1783320729846022144
author Babaev, Olga
Piletti Chatain, Carolina
Krueger-Burg, Dilja
author_facet Babaev, Olga
Piletti Chatain, Carolina
Krueger-Burg, Dilja
author_sort Babaev, Olga
collection PubMed
description Inhibitory neurotransmission plays a key role in anxiety disorders, as evidenced by the anxiolytic effect of the benzodiazepine class of γ-aminobutyric acid (GABA) receptor agonists and the recent discovery of anxiety-associated variants in the molecular components of inhibitory synapses. Accordingly, substantial interest has focused on understanding how inhibitory neurons and synapses contribute to the circuitry underlying adaptive and pathological anxiety behaviors. A key element of the anxiety circuitry is the amygdala, which integrates information from cortical and thalamic sensory inputs to generate fear and anxiety-related behavioral outputs. Information processing within the amygdala is heavily dependent on inhibitory control, although the specific mechanisms by which amygdala GABAergic neurons and synapses regulate anxiety-related behaviors are only beginning to be uncovered. Here, we summarize the current state of knowledge and highlight open questions regarding the role of inhibition in the amygdala anxiety circuitry. We discuss the inhibitory neuron subtypes that contribute to the processing of anxiety information in the basolateral and central amygdala, as well as the molecular determinants, such as GABA receptors and synapse organizer proteins, that shape inhibitory synaptic transmission within the anxiety circuitry. Finally, we conclude with an overview of current and future approaches for converting this knowledge into successful treatment strategies for anxiety disorders.
format Online
Article
Text
id pubmed-5938054
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-59380542018-05-15 Inhibition in the amygdala anxiety circuitry Babaev, Olga Piletti Chatain, Carolina Krueger-Burg, Dilja Exp Mol Med Review Article Inhibitory neurotransmission plays a key role in anxiety disorders, as evidenced by the anxiolytic effect of the benzodiazepine class of γ-aminobutyric acid (GABA) receptor agonists and the recent discovery of anxiety-associated variants in the molecular components of inhibitory synapses. Accordingly, substantial interest has focused on understanding how inhibitory neurons and synapses contribute to the circuitry underlying adaptive and pathological anxiety behaviors. A key element of the anxiety circuitry is the amygdala, which integrates information from cortical and thalamic sensory inputs to generate fear and anxiety-related behavioral outputs. Information processing within the amygdala is heavily dependent on inhibitory control, although the specific mechanisms by which amygdala GABAergic neurons and synapses regulate anxiety-related behaviors are only beginning to be uncovered. Here, we summarize the current state of knowledge and highlight open questions regarding the role of inhibition in the amygdala anxiety circuitry. We discuss the inhibitory neuron subtypes that contribute to the processing of anxiety information in the basolateral and central amygdala, as well as the molecular determinants, such as GABA receptors and synapse organizer proteins, that shape inhibitory synaptic transmission within the anxiety circuitry. Finally, we conclude with an overview of current and future approaches for converting this knowledge into successful treatment strategies for anxiety disorders. Nature Publishing Group UK 2018-04-09 /pmc/articles/PMC5938054/ /pubmed/29628509 http://dx.doi.org/10.1038/s12276-018-0063-8 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. If you remix, transform, or build upon this article or a part thereof, you must distribute your contributions under the same license as the original. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/.
spellingShingle Review Article
Babaev, Olga
Piletti Chatain, Carolina
Krueger-Burg, Dilja
Inhibition in the amygdala anxiety circuitry
title Inhibition in the amygdala anxiety circuitry
title_full Inhibition in the amygdala anxiety circuitry
title_fullStr Inhibition in the amygdala anxiety circuitry
title_full_unstemmed Inhibition in the amygdala anxiety circuitry
title_short Inhibition in the amygdala anxiety circuitry
title_sort inhibition in the amygdala anxiety circuitry
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938054/
https://www.ncbi.nlm.nih.gov/pubmed/29628509
http://dx.doi.org/10.1038/s12276-018-0063-8
work_keys_str_mv AT babaevolga inhibitionintheamygdalaanxietycircuitry
AT pilettichataincarolina inhibitionintheamygdalaanxietycircuitry
AT kruegerburgdilja inhibitionintheamygdalaanxietycircuitry